The organ care system market size was valued at USD 0.62 billion in 2024 and is expected to reach USD 1.85 billion by 2032, growing at a CAGR of 14.67% over 2025-2032.
The organ care system market is developing due to increasing numbers of transplants, increasing awareness of organ viability preservation, and technological advances leading to higher success rates post-transplant. Increased demand for advanced organ care systems is likely in the coming years, with global demand for organ transplants exceeding 150,000 in 2023 and close to 20% of viable organs becoming unusable due to preservation restrictions. Increasing demand for organ care systems in the developed regions, such as the US, which is equipped with a high-quality healthcare system, is driven by reimbursement models. Furthermore, the market growth is driven by rising R&D spending. TransMedics, for instance, made large investments in clinical trials and device refinement, and organ care system companies such as XVIVO Perfusion and Paragonix Technologies are continually releasing new portable and AI (artificial intelligence) devices.
Regulatory agencies, including the FDA, have expedited the approval process for normothermic perfusion devices, allowing rapid dissemination across transplant centers. Heart and lung perfusion systems companies also have a major share in the organ care system market, owing to the high demand for these organs. Some of the factors driving the organ care system market growth are the shortage of donor organs, along with the long waiting lists, the rise in the acceptance of marginal donors, and the use of AI-incorporated preservation systems. Supply-side enhancements, such as smart transport systems and prolonged preservation time, also add to the organ care system market analysis. Public-private-based DoD-funded initiatives and growing acceptance in academic medical centers bring innovation and improved patient outcomes, which act as a major impact provider to the organ care systems market analysis.
In March 2024, XVIVO Perfusion reported that its transportable lung perfusion system has been successfully tested, improving logistics in transplants and gaining market share for its organ care system.
Market Dynamics:
Drivers:
Rising Transplant Demand & Technological Advancements Fueling Adoption Fuel the Market Growth
The increasing number of transplants needs both locally and abroad, preservation technology advancement, and growing investment in R&D will continue to propel the organ care system market. More than 1.5 million patients globally are awaiting organ transplants, and only a small percentage of available donor organs meet the criteria for transplantation, making it necessary to develop new technologies that can extend organ viability. Advanced perfusion technologies, particularly hypothermic and normothermic machine perfusion, are emerging as a vital tool for increasing the number of available organs. Next-generation liver and kidney perfusion devices have been developed by companies including OrganOx and Bridge to Life that can extend preservation times and increase post-transplant recovery rates by as much as 30 per cent. In addition, interest in investing in climate tech has picked up, and several climate tech startups have raised a combined more than USD 300 million since 2021.
Regulatory backing is also playing an important role in accelerating the organ care system market share. For instance, OrganOx’s Metra device received the FDA Priority Review Designation, allowing manufacturers to streamline the trials and review processes. In addition, the increasing acceptance of marginal donors (MD) and ECD is driving demand for real-time monitoring and ex vivo perfusion solutions, adding to the supply-side momentum. These concerted trends are influencing the organ care system market trends towards increased clinical efficacy, less wastage, and better patient outcomes.
Restraints:
High Capital Costs & Operational Complexities Limiting Adoption
High capital and operational expenditure linked with these sophisticated systems is one of the major factors that limit the growth of the market. The majority of perfusion systems are priced at USD 200,000-350,000 per unit, and disposable and maintenance costs are not included, which places these systems out of reach of small transplant centers and low-income hospitals. Moreover, the requirement of skilled personnel to manage and control perfusion systems also during transportation or pre-operative periods, restrains the use in decentralized environments. Supply chain inconsistencies, including the availability of perfusate solutions and sterile consumables, add further barriers to seamless application, especially in remote or underdeveloped areas.
There are also still regulatory hurdles, as manufacturers have to go through multi-stage clinical validation and conform to changing standards such as the EU MDR and FDA’s 21 CFR Part 820, which postpone time-to-market. Assessing barriers to the utilization of portable perfusion systems during a February 2023 industry survey, 41% of transplant hospitals identified reimbursement uncertainty and complexity associated with portable perfusion as significant barriers to adoption. Furthermore, in-hospital connectivity to EHR and transplant workflow systems is suboptimal and currently does not allow for real-time syncing of data. These challenges that are related to cost, training, and infrastructure are hindering the full-scale adoption and restricting the organ care system market growth in many potential use settings.
Segmentation Analysis:
By Organ Type
In 2024, the heart segment led the market for organ care systems, with more than 36.5% of the market share. This has been due to the high prevalence of cardiovascular diseases at the global level and the essential role of maintaining cardiac viability of real-time perfusion to be integrated during transport. Devices such as the TransMedics OCS Heart are increasingly used because of the possibility to extend preservation time and functionally assess the heart before transplantation.
Lung segment is the fastest growing segment, owing to increased acceptance of marginal donors and a surge in demand for ex vivo lung perfusion (EVLP). Technologies like XVIVO’s lung perfusion system and the larger success rates in transplanting organs are continuing to drive hospitals to utilise lung-specific organ care technologies.
By Technology
Machine perfusion was the dominant segment in 2024 and accounted for more than 42.3% of the total revenue. Having the potential to preserve organ function, decrease ischemia-reperfusion injury, and evaluate viability in situ, compared to static storage, SSS is advantageous, especially for marginal organs.
Normothermic regional perfusion (NRP) is a rapidly expanding field in EVLP, which facilitates in situ organ recovery in almost physiological circumstances. The rise in usage in DCD cases and support by regulators in Europe and North America is driving its use.
By Product Type
Perfusion systems accounted for 39.8% in terms of revenue in the year 2024, as they were utilized significantly for the evaluation of organ viability and long-distance transportation. The availability of FDA-approved devices for heart and liver perfusion and the growth of hospital-based transplant programs are additional factors promoting their acceptance.
Monitoring systems are rapidly expanding, as the transplant teams require constant information on temperature, flow, pressure, and oxygenation during transport. The rise in the segment is driven by the changeover from dumb to smart, artificial intelligence-integrated tracking platforms.
By Application
In 2024, organ transplantation continued to dominate the market, accounting for more than 61.2% owing to increasing multi-organ transplantation globally and an increase in the use of perfusion systems in donor-recipient logistics.
Remote monitoring and transport tracking are becoming among the fastest-growing applications, with increasing pressure for data-driven logistics and transparency in organ transfer. They are being driven by startups that provide integrated GPS and IoT-enabled tracking solutions.
By End User
The transplant centers segment dominated the market in 2024, as these can receive organs, evaluate, and use advanced techniques of perfusion systems and have a direct impact on the success rate of transplants.
OPOs will be the most rapidly growing end users, with the expanding use of mobile perfusion systems and cloud-based platforms to improve coordination, cut cold ischemia time, and increase the rate of organ acceptance across larger geographies.
Regional Analysis:
North America was the leading revenue-generating region in 2024, driven by its well-developed healthcare infrastructure and high organ transplant rates, along with stringent government regulations.
The U.S. organ care system market size was valued at USD 0.24 billion in 2024 and is expected to reach USD 0.67 billion by 2032, growing at a CAGR of 14.04% over 2025-2032. The U.S. dominated the market due to the existence of major organ care system players and a large number of transplants, because of the highest demand for organ transplantation, with statistics published by UNOS indicating more than 42,000 transplants in 2023. Market players' augmented investment in R&D and uptake of the leading-edge perfusion techniques, including normothermic machine perfusion, ensured market dominance. Canada also performed well, fuelled by strong governmental backing and an increasing donor registry rate. The U.S. is also the fastest-growing market in the region, driven by advancements in the field of organ monitoring devices and logistics systems with AI platforms.
Europe was the second organ care system market share holder in 2024 on account of established transplant networks, growing awareness, and EU-funded programs for organ donation. Germany was the leading country in the region in terms of transplant procedures, due to rising investment in healthcare development and the presence of well-developed transplant centers. France and the United Kingdom are also among the biggest donors, diversified by legal changes to mandate organ donation. The UK largest growing country in the region, and more than 4,600 organ transplants were performed in 2023, supported by the “opt-out” organ donation legislation and the increasing usage of machine perfusion technology.
Asia Pacific is growing at the highest CAGR in the global organ care system market, driven by growing government steps, escalating development in the healthcare infrastructure, and the growing incidence of organ failure resulting from the growing dialysis population. China leads because of its growing transplant system based on investments made by the National Health Commission in organ-sharing networks and in logistic enhancements. India is observing the highest growth in the region for increasing deceased donor awareness, the success of the public-private partnership programs, and the introduction of cloud-based transport tracking solutions. Japan and South Korea are also spending heavily on R&D, lifting regional growth too.
Leading organ care system companies in the market include TransMedics Inc., XVIVO Perfusion AB, OrganOx Limited, Paragonix Technologies Inc., Bridge to Life Ltd, Organ Recovery Systems Inc., Organ Assist B.V., Water Medical System LLC, Preservation Solutions Inc., Organ Transport System Inc., Perfusion Solutions Inc., Stealth BioTherapeutics, Medical Solutions Inc., AlloSource, Cellerate, Organogenesis Inc., Tissue Regenix Group, Vital Therapies Inc., LifeShare Transplant Donor Services, and Tandem Diabetes Care Inc.
In May 2024, TransMedics announced the expansion of its OCS Lung platform trials to include broader donor and recipient profiles in the U.S., aiming to enhance utilization rates and reduce waiting times for lung transplants.
In January 2024, XVIVO Perfusion AB received CE Mark approval for its new portable organ perfusion system designed for heart and liver preservation, enabling real-time monitoring and transport across longer distances in Europe.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 0.62 billion |
| Market Size by 2032 | USD 1.85 billion |
| CAGR | CAGR of 14.67% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Organ Type (Heart, Liver, Kidney, Lung, Pancreas, and Others (intestines, composite tissues like face/limbs, multi-organ systems for research)) • By Technology (Machine Perfusion (normothermic, hypothermic), Static Cold Storage (basic, enhancers), Normothermic Regional Perfusion, and Cold Storage Technology) • By Product Type (Perfusion Systems, Organ Preservation Solutions, Transportation Systems, Monitoring Devices, and Others (logistics software, hybrid organ care kits)) • By Application (Organ Transplantation, Research & Development, In-Hospital Organ Preservation, Remote Monitoring & Transport Tracking) • By End User (Hospitals, Transplant Centers, Organ Procurement Organizations, Research Institutes & Clinical Laboratories, and Others (ambulatory surgical centers, academic transplant units, mobile transplant programs)) |
| Regional Analysis/Coverage | North America (U.S., Canada), Europe (Germany, France, UK, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America) |
| Company Profiles | TransMedics Inc., XVIVO Perfusion AB, OrganOx Limited, Paragonix Technologies Inc., Bridge to Life Ltd, Organ Recovery Systems Inc., Organ Assist B.V., Water Medical System LLC, Preservation Solutions Inc., Organ Transport System Inc., Perfusion Solutions Inc., Stealth BioTherapeutics, Medical Solutions Inc., AlloSource, Cellerate, Organogenesis Inc., Tissue Regenix Group, Vital Therapies Inc., LifeShare Transplant Donor Services, and Tandem Diabetes Care Inc. |
Ans: The Organ Care System market is projected to reach USD 0.71 billion by 2025, driven by increased transplant demand. It is expected to grow at a CAGR of 14.67% through 2032.
Ans: Key players include TransMedics Inc., XVIVO Perfusion AB, Paragonix Technologies, OrganOx Ltd, and Bridge to Life Ltd, among others. These companies lead in perfusion and transport technologies.
Ans: Rising organ transplant volumes, improved patient outcomes, and adoption of normothermic perfusion systems are key drivers. Supportive regulatory approvals and R&D funding also fuel growth.
Ans: North America dominates the market due to strong transplant infrastructure and reimbursement support. Europe is the second-largest, with rapid growth in Germany and the U.K.
Ans: Recent advancements include normothermic machine perfusion, portable organ care devices, and smart monitoring for real-time organ function assessment during transport.
Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Organ Type
2.3.2 Market Size By Technology
2.3.3 Market Size By Product Type
2.3.4 Market Size By Application
2.3.5 Market Size By End User
2.4 Market Share & BPS Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Life Cycle Assessment
3.5 Parent Market Overview
3.6 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Reimbursement & Coverage Trends
4.1.1 Country-wise Payer Coverage Analysis
4.1.2 Cost-Effectiveness and HTA Trends
4.2 R&D Investment and Funding Trends
4.2.1 Venture Capital and IPO Activity (2020–2024)
4.2.2 Public-Private and Regulatory-Backed Initiatives
4.3 Technology Integration Trends
4.3.1 AI and Predictive Analytics
4.3.2 Cloud-Based Platforms and Registry Integration
4.4 Clinical Trials and Pipeline Progression Metrics
4.4.1 Clinical Trials by Organ and Technology Type
4.4.2 Enrollment and Access Trends
4.5 Adoption and Utilization Trends
4.5.1 Machine Perfusion Adoption Rate
4.5.2 Organ Preservation Efficiency and Usage
5. Organ Care System Market Segmental Analysis & Forecast, By Organ Type, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Heart
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Liver
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Kidney
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.5 Lung
5.5.1 Key Trends
5.5.2 Market Size & Forecast, 2021 – 2032
5.6 Pancreas
5.6.1 Key Trends
5.6.2 Market Size & Forecast, 2021 – 2032
5.7 Others (Intestines, composite tissue (e.g., face, limbs), and multi-organ systems used in research or rare procedures)
5.7.1 Key Trends
5.7.2 Market Size & Forecast, 2021 – 2032
6. Organ Care System Market Segmental Analysis & Forecast, By Technology, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Machine Perfusion
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.2.3 Normothermic Machine Perfusion
6.2.3.1 Key Trends
6.2.3.2 Market Size & Forecast, 2021 – 2032
6.2.4 Hypothermic Machine Perfusion
6.2.4.1 Key Trends
6.2.4.2 Market Size & Forecast, 2021 – 2032
6.3 Static Cold Storage
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.3.3 Basic Cold Storage
6.3.3.1 Key Trends
6.3.3.2 Market Size & Forecast, 2021 – 2032
6.3.4 Static Cold Storage Enhancers
6.3.4.1 Key Trends
6.3.4.2 Market Size & Forecast, 2021 – 2032
6.4 Normothermic Regional Perfusion
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
6.5 Cold Storage Technology
6.5.1 Key Trends
6.5.2 Market Size & Forecast, 2021 – 2032
7. Organ Care System Market Segmental Analysis & Forecast, By Product Type, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Perfusion Systems
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Organ Preservation Solutions
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Transportation Systems
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.5 Monitoring Devices
7.5.1 Key Trends
7.5.2 Market Size & Forecast, 2021 – 2032
7.6 Others (Logistics software platforms, integrated cloud-based data solutions, or hybrid organ care kits)
7.6.1 Key Trends
7.6.2 Market Size & Forecast, 2021 – 2032
8. Organ Care System Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Organ Transplantation
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Research & Development
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 In-Hospital Organ Preservation
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Remote Monitoring and Transport Tracking
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
9. Organ Care System Market Segmental Analysis & Forecast, By End User, 2021 – 2032, Value (USD Billion)
9.1 Introduction
9.2 Hospitals
9.2.1 Key Trends
9.2.2 Market Size & Forecast, 2021 – 2032
9.3 Transplant Centers
9.3.1 Key Trends
9.3.2 Market Size & Forecast, 2021 – 2032
9.4 Organ Procurement Organizations (OPOs)
9.4.1 Key Trends
9.4.2 Market Size & Forecast, 2021 – 2032
9.5 Research Institutes & Clinical Laboratories
9.5.1 Key Trends
9.5.2 Market Size & Forecast, 2021 – 2032
9.6 Others (Ambulatory surgical centers, academic transplant units, and mobile transplant programs)
9.6.1 Key Trends
9.6.2 Market Size & Forecast, 2021 – 2032
10. Organ Care System Market Segmental Analysis & Forecast By Region, 2021 – 2032, Value (USD Billion)
10.1 Introduction
10.2 North America
10.2.1 Key Trends
10.2.2 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.2.3 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.2.4 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.2.5 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.2.6 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.2.7 Organ Care System Market Size & Forecast, By Country, 2021 – 2032
10.2.7.1 USA
10.2.7.1.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.2.7.1.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.2.7.1.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.2.7.1.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.2.7.1.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.2.7.2 Canada
10.2.7.2.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.2.7.2.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.2.7.2.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.2.7.2.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.2.7.2.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.3 Europe
10.3.1 Key Trends
10.3.2 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.3.3 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.3.4 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.3.5 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.3.6 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.3.7 Organ Care System Market Size & Forecast, By Country, 2021 – 2032
10.3.7.1 Germany
10.3.7.1.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.3.7.1.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.1.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.3.7.1.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.3.7.1.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.3.7.2 UK
10.3.7.2.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.3.7.2.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.2.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.3.7.2.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.3.7.2.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.3.7.3 France
10.3.7.3.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.3.7.3.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.3.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.3.7.3.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.3.7.3.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.3.7.4 Italy
10.3.7.4.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.3.7.4.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.4.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.3.7.4.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.3.7.4.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.3.7.5 Spain
10.3.7.5.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.3.7.5.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.5.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.3.7.5.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.3.7.5.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.3.7.6 Russia
10.3.7.6.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.3.7.6.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.6.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.3.7.6.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.3.7.6.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.3.7.7 Poland
10.3.7.7.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.3.7.7.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.7.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.3.7.7.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.3.7.7.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.3.7.8 Rest of Europe
10.3.7.8.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.3.7.8.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.8.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.3.7.8.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.3.7.8.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.4 Asia-Pacific
10.4.1 Key Trends
10.4.2 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.4.3 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.4.4 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.4.5 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.4.6 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.4.7 Organ Care System Market Size & Forecast, By Country, 2021 – 2032
10.4.7.1 China
10.4.7.1.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.4.7.1.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.1.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.4.7.1.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.4.7.1.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.4.7.2 India
10.4.7.2.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.4.7.2.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.2.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.4.7.2.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.4.7.2.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.4.7.3 Japan
10.4.7.3.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.4.7.3.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.3.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.4.7.3.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.4.7.3.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.4.7.4 South Korea
10.4.7.4.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.4.7.4.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.4.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.4.7.4.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.4.7.4.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.4.7.5 Australia
10.4.7.5.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.4.7.5.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.5.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.4.7.5.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.4.7.5.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.4.7.6 ASEAN Countries
10.4.7.6.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.4.7.6.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.6.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.4.7.6.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.4.7.6.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.4.7.7 Rest of Asia-Pacific
10.4.7.7.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.4.7.7.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.7.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.4.7.7.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.4.7.7.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.5 Latin America
10.5.1 Key Trends
10.5.2 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.5.3 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.5.4 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.5.5 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.5.6 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.5.7 Organ Care System Market Size & Forecast, By Country, 2021 – 2032
10.5.7.1 Brazil
10.5.7.1.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.5.7.1.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.5.7.1.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.5.7.1.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.5.7.1.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.5.7.2 Argentina
10.5.7.2.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.5.7.2.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.5.7.2.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.5.7.2.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.5.7.2.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.5.7.3 Mexico
10.5.7.3.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.5.7.3.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.5.7.3.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.5.7.3.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.5.7.3.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.5.7.4 Colombia
10.5.7.4.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.5.7.4.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.5.7.4.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.5.7.4.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.5.7.4.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.5.7.5 Rest of Latin America
10.5.7.5.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.5.7.5.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.5.7.5.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.5.7.5.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.5.7.5.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.6 Middle East & Africa
10.6.1 Key Trends
10.6.2 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.6.3 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.6.4 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.6.5 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.6.6 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.6.7 Organ Care System Market Size & Forecast, By Country, 2021 – 2032
10.6.7.1 UAE
10.6.7.1.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.6.7.1.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.1.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.6.7.1.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.6.7.1.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.6.7.2 Saudi Arabia
10.6.7.2.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.6.7.2.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.2.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.6.7.2.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.6.7.2.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.6.7.3 Qatar
10.6.7.3.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.6.7.3.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.3.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.6.7.3.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.6.7.3.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.6.7.4 Egypt
10.6.7.4.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.6.7.4.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.4.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.6.7.4.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.6.7.4.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.6.7.5 South Africa
10.6.7.5.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.6.7.5.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.5.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.6.7.5.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.6.7.5.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
10.6.7.6 Rest of Middle East & Africa
10.6.7.6.1 Organ Care System Market Size & Forecast, By Organ Type, 2021 – 2032
10.6.7.6.2 Organ Care System Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.6.3 Organ Care System Market Size & Forecast, By Product Type, 2021 – 2032
10.6.7.6.4 Organ Care System Market Size & Forecast, By Application, 2021 – 2032
10.6.7.6.5 Organ Care System Market Size & Forecast, By End User, 2021 – 2032
11. Competitive Landscape
11.1 Key Players' Positioning
11.2 Competitive Developments
11.2.1 Key Strategies Adopted (%), By Key Players, 2024
11.2.2 Year-Wise Strategies & Development, 2021 – 2025
11.2.3 Number of Strategies Adopted by Key Players, 2024
11.3 Market Share Analysis, 2024
11.4 Product/Service & Application Benchmarking
11.4.1 Product/Service Specifications & Features By Key Players
11.4.2 Product/Service Heatmap By Key Players
11.4.3 Application Heatmap By Key Players
11.5 Industry Start-Up & Innovation Landscape
11.6 Key Company Profiles
11.6 Key Company Profiles
11.6.1 TransMedics Inc.
11.6.1.1 Company Overview & Snapshot
11.6.1.2 Product/Service Portfolio
11.6.1.3 Key Company Financials
11.6.1.4 SWOT Analysis
11.6.2 XVIVO Perfusion AB
11.6.2.1 Company Overview & Snapshot
11.6.2.2 Product/Service Portfolio
11.6.2.3 Key Company Financials
11.6.2.4 SWOT Analysis
11.6.3 OrganOx Limited
11.6.3.1 Company Overview & Snapshot
11.6.3.2 Product/Service Portfolio
11.6.3.3 Key Company Financials
11.6.3.4 SWOT Analysis
11.6.4 Paragonix Technologies Inc.
11.6.4.1 Company Overview & Snapshot
11.6.4.2 Product/Service Portfolio
11.6.4.3 Key Company Financials
11.6.4.4 SWOT Analysis
11.6.5 Bridge to Life Ltd
11.6.5.1 Company Overview & Snapshot
11.6.5.2 Product/Service Portfolio
11.6.5.3 Key Company Financials
11.6.5.4 SWOT Analysis
11.6.6 Organ Recovery Systems Inc.
11.6.6.1 Company Overview & Snapshot
11.6.6.2 Product/Service Portfolio
11.6.6.3 Key Company Financials
11.6.6.4 SWOT Analysis
11.6.7 Organ Assist B.V.
11.6.7.1 Company Overview & Snapshot
11.6.7.2 Product/Service Portfolio
11.6.7.3 Key Company Financials
11.6.7.4 SWOT Analysis
11.6.8 Water Medical System LLC
11.6.8.1 Company Overview & Snapshot
11.6.8.2 Product/Service Portfolio
11.6.8.3 Key Company Financials
11.6.8.4 SWOT Analysis
11.6.9 Preservation Solutions Inc.
11.6.9.1 Company Overview & Snapshot
11.6.9.2 Product/Service Portfolio
11.6.9.3 Key Company Financials
11.6.9.4 SWOT Analysis
11.6.10 Organ Transport System Inc.
11.6.10.1 Company Overview & Snapshot
11.6.10.2 Product/Service Portfolio
11.6.10.3 Key Company Financials
11.6.10.4 SWOT Analysis
11.6.11 Perfusion Solutions Inc.
11.6.11.1 Company Overview & Snapshot
11.6.11.2 Product/Service Portfolio
11.6.11.3 Key Company Financials
11.6.11.4 SWOT Analysis
11.6.12 Stealth BioTherapeutics
11.6.12.1 Company Overview & Snapshot
11.6.12.2 Product/Service Portfolio
11.6.12.3 Key Company Financials
11.6.12.4 SWOT Analysis
11.6.13 Medical Solutions Inc.
11.6.13.1 Company Overview & Snapshot
11.6.13.2 Product/Service Portfolio
11.6.13.3 Key Company Financials
11.6.13.4 SWOT Analysis
11.6.14 AlloSource
11.6.14.1 Company Overview & Snapshot
11.6.14.2 Product/Service Portfolio
11.6.14.3 Key Company Financials
11.6.14.4 SWOT Analysis
11.6.15 Cellerate
11.6.15.1 Company Overview & Snapshot
11.6.15.2 Product/Service Portfolio
11.6.15.3 Key Company Financials
11.6.15.4 SWOT Analysis
11.6.16 Organogenesis Inc.
11.6.16.1 Company Overview & Snapshot
11.6.16.2 Product/Service Portfolio
11.6.16.3 Key Company Financials
11.6.16.4 SWOT Analysis
11.6.17 Tissue Regenix Group
11.6.17.1 Company Overview & Snapshot
11.6.17.2 Product/Service Portfolio
11.6.17.3 Key Company Financials
11.6.17.4 SWOT Analysis
11.6.18 Vital Therapies Inc.
11.6.18.1 Company Overview & Snapshot
11.6.18.2 Product/Service Portfolio
11.6.18.3 Key Company Financials
11.6.18.4 SWOT Analysis
11.6.19 LifeShare Transplant Donor Services
11.6.19.1 Company Overview & Snapshot
11.6.19.2 Product/Service Portfolio
11.6.19.3 Key Company Financials
11.6.19.4 SWOT Analysis
11.6.20 Tandem Diabetes Care Inc.
11.6.20.1 Company Overview & Snapshot
11.6.20.2 Product/Service Portfolio
11.6.20.3 Key Company Financials
11.6.20.4 SWOT Analysis
12. Analyst Recommendations
12.1 SNS Insider Opportunity Map
12.2 Industry Low-Hanging Fruit Assessment
12.3 Market Entry & Growth Strategy
12.4 Analyst Viewpoint & Suggestions On Market Growth
13. Assumptions
14. Disclaimer
15. Appendix
15.1 List Of Tables
15.2 List Of Figures
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Organ Type
By Technology
By Product Type
By Application
By End User
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report: